ArticleChemMedChem2026

Development of Styryl-Modified 3,4-Dihydropyrimidin-2(1H)-ones as Potential Antitumor Agents.

Konstantinos Panagoulias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.